Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 19, Issue 6, Pages 267-272
http://dx.doi.org/10.1155/2004/834309

Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer

Daniel Ayude,1 María Páez de la Cadena,1 Oscar Javier Cordero,2 Montserrat Nogueira,2 José Ayude,3 Almudena Fernández-Briera,1 and Francisco Javier Rodríguez-Berrocal1

1Department of Biochemistry, Genetics, and Immunology, University of Vigo, 36200 Vigo, Spain
2Department of Biochemistry and Molecular Biology, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
3Department of Computer Sciences, University of Vigo, 36200 Vigo, Spain

Received 13 July 2004; Accepted 13 July 2004

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Daniel Ayude, María Páez de la Cadena, Oscar Javier Cordero, et al., “Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer,” Disease Markers, vol. 19, no. 6, pp. 267-272, 2004. https://doi.org/10.1155/2004/834309.